These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30193247)

  • 1. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply.
    Bradford AC; Abraham A; Bagwell Adams G
    JAMA Intern Med; 2018 Sep; 178(9):1281-1282. PubMed ID: 30193247
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use-Reply.
    Hockenberry JM; Wen H
    JAMA Intern Med; 2018 Sep; 178(9):1282. PubMed ID: 30193248
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid Death Rate Acceleration in Jurisdictions Legalizing Marijuana Use.
    Bleyer A; Barnes B
    JAMA Intern Med; 2018 Sep; 178(9):1280-1281. PubMed ID: 30193245
    [No Abstract]   [Full Text] [Related]  

  • 4. United States marijuana legalization and opioid mortality epidemic during 2010-2020 and pandemic implications.
    Bleyer A; Barnes B; Finn K
    J Natl Med Assoc; 2022 Aug; 114(4):412-425. PubMed ID: 35469600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance.
    Wen J; Wen H; Butler JS; Talbert JC
    Health Econ; 2021 May; 30(5):989-1000. PubMed ID: 33624387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Marijuana Laws, Marijuana Use, and Opioid-Related Outcomes among Women in the United States.
    Ali MM; McClellan C; West KD; Mutter R
    Womens Health Issues; 2021; 31(1):24-30. PubMed ID: 33069561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. United States marijuana legalization and opioid mortality trends before and during the first year of the COVID-19 pandemic.
    Bleyer A; Barnes B; Finn K
    J Opioid Manag; 2024; 20(2):119-132. PubMed ID: 38700393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing cannabis: only by pain physicians?].
    Maier C; Muth L; Glaeske G
    Schmerz; 2021 Dec; 35(6):436-438. PubMed ID: 34491434
    [No Abstract]   [Full Text] [Related]  

  • 9. An Ethical Framework to Manage Patient Requests for Medical Marijuana.
    Redinger M; Fledderman N; Crutchfield P
    J Am Board Fam Med; 2020; 33(1):147-151. PubMed ID: 31907257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.
    Wen H; Hockenberry JM
    JAMA Intern Med; 2018 May; 178(5):673-679. PubMed ID: 29610827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Board Expectations for Physicians Recommending Marijuana.
    Chaudhry HJ; Hengerer AS; Snyder GB
    JAMA; 2016 Aug; 316(6):577-8. PubMed ID: 27308872
    [No Abstract]   [Full Text] [Related]  

  • 12. An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain.
    Darnall BD; Humphreys KN
    Addiction; 2018 Aug; 113(8):1552-1553. PubMed ID: 29882256
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabis based drugs: how will they be used in practice?
    Hawkes N
    BMJ; 2018 Nov; 363():k4665. PubMed ID: 30560790
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis as a Substitute for Opioids-Reply.
    Humphreys K; Saitz R
    JAMA; 2019 Jul; 322(3):273-274. PubMed ID: 31310294
    [No Abstract]   [Full Text] [Related]  

  • 15. Colorado tackles medical implications of marijuana.
    Wolk L; Kuehn BM
    JAMA; 2014 May; 311(20):2053-4. PubMed ID: 24828256
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary on Sarvet et al. (2018): What do we still need to know about the impacts of medical marijuana laws in the United States?
    Chu YL
    Addiction; 2018 Jun; 113(6):1017-1018. PubMed ID: 29732703
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabis-based medicinal products and the role of the doctor: should we be cautious or cautiously optimistic?
    Braithwaite I; Newton-Howes G; Oldfield K; Semprini A
    N Z Med J; 2019 Aug; 132(1500):82-88. PubMed ID: 31415502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Cannabis Legalization in the Opioid Crisis.
    Hill KP; Saxon AJ
    JAMA Intern Med; 2018 May; 178(5):679-680. PubMed ID: 29610836
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential Impact of Medical Marijuana on Nonmedical Opioid Use.
    Theriault BM; Schlesinger JJ
    Am J Psychiatry; 2018 Mar; 175(3):284. PubMed ID: 29490499
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical Marijuana and the Opioid Epidemic: Response to Theriault and Schlesinger.
    Olfson M; Wall MM; Blanco C
    Am J Psychiatry; 2018 Mar; 175(3):284-285. PubMed ID: 29490498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.